HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wuyan Zhang Selected Research

PF-06410293

6/2022Usability Study of PF-06410293, an Adalimumab Biosimilar, by Prefilled Pen: Open-Label, Single-Arm, Sub-Study of a Phase 3 Trial in Patients with Rheumatoid Arthritis.
1/2021Randomised study of PF-06410293, an adalimumab (ADL) biosimilar, compared with reference ADL for the treatment of active rheumatoid arthritis: results from weeks 26-52, including a treatment switch from reference ADL to PF-06410293.
1/2021Long-term efficacy, safety, and immunogenicity of the adalimumab biosimilar, PF-06410293, in patients with rheumatoid arthritis after switching from reference adalimumab (Humira®) or continuing biosimilar therapy: week 52-92 data from a randomized, double-blind, phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wuyan Zhang Research Topics

Disease

4Chronic Renal Insufficiency
06/2015 - 04/2011
3Rheumatoid Arthritis
06/2022 - 01/2021
3Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
12/2012 - 01/2011
2Hypercalcemia (Milk Alkali Syndrome)
06/2015 - 02/2012
1Secondary Hyperparathyroidism
06/2015
1Cognitive Dysfunction
10/2014
1Cushing Syndrome
10/2014
1Alzheimer Disease (Alzheimer's Disease)
10/2014
1Renal Insufficiency (Renal Failure)
04/2011
1Kidney Diseases (Kidney Disease)
01/2011

Drug/Important Bio-Agent (IBA)

4paricalcitol (Zemplar)FDA Link
06/2015 - 04/2011
3Biosimilar PharmaceuticalsIBA
06/2022 - 01/2021
3Adalimumab (Humira)FDA Link
06/2022 - 01/2021
3PF-06410293IBA
06/2022 - 01/2021
3Calcitriol Receptors (Calcitriol Receptor)IBA
06/2015 - 01/2011
2Vitamin DFDA LinkGeneric
12/2012 - 02/2012
1Calcitriol (Calcijex)FDA LinkGeneric
06/2015
1maxacalcitolIBA
06/2015
1Parathyroid Hormone (Parathormone)IBA
06/2015
1Oxidoreductases (Dehydrogenase)IBA
10/2014
1N- (5- (aminocarbonyl)tricyclo(3.3.1.13,7)dec- 2- yl)- alpha,alpha- dimethyl- 4- (5- (trifluoromethyl)- 2- pyridinyl)- 1- piperazineacetamideIBA
10/2014
1Hydrocortisone (Cortisol)FDA LinkGeneric
10/2014

Therapy/Procedure

3Therapeutics
01/2021 - 04/2011
2Activities of Daily Living (ADL)
06/2022 - 01/2021
1Renal Dialysis (Hemodialysis)
06/2015